跳至主要内容
临床试验/IRCT20210823052264N4
IRCT20210823052264N4招募中3 期

Comparison of Efficacy of Intravenous Versus Intramuscular Injection Meglumine Antimoniate in patients of Cutaneous Leishmaniasis

CMH Quetta0 个研究点目标入组 90 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
招募中
发起方
入组人数
90

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
15 years 至 80 years(—)
性别
All

入选标准

  • All patients with biopsy proven leishmaniasis plus any of the following: has lesion(s) located in sites not compatible with local treatment for example eyelids
  • lesions in which scaring would be disabling or severely disfiguring like on face
  • lesions that will have difficulting in healing like on lower limb or over a joint
  • lesions involving mucosa or cartilage
  • lesion =4 cm
  • lesion with sporotrichoid spread
  • multiple lesions

排除标准

  • patients allergic to antimonials
  • the lesion is already self-curing
  • pregnant and breast feeding women
  • those who refused to accept the diagnostic procedures
  • patients having mucosal, mucocutaneous or visceral leishmaniasis
  • Patients with comorbidity (diabetes, hypertension,chronic liver disease,chronic kidney disease) and/or immunosuppression
  • Patients with baseline ECG abnormalities/Heart disease

研究者

发起方
CMH Quetta

相似试验